Vaccines and monoclonal antibody treatments to prevent severe coronavirus disease 2019
(COVID-19) illness were available within a year of the pandemic being declared but there …

Infection with SARS-CoV-2, the causative agent of the Coronavirus disease 2019 (COVID-
19) pandemic, causes respiratory problems and multifaceted organ dysfunction. A crucial …

The global spread of SARS-CoV-2 points to unrivaled mutational variation of the virus,
contributing to a variety of post-COVID sequelae in immunocompromised subjects and high …

A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …

Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …

Objectives To investigate whether the risk of developing an incident autoimmune disease is
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …

Background: Though primarily a pulmonary disease, Coronavirus disease 2019 (COVID-19)
caused by the SARS-CoV-2 virus can generate devastating disease states that affect …

Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

Although many people infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) recover completely, others are left with long-lasting symptoms that persist for …

Die Deutsche Gesellschaft für Pneumologie hat 2021 die AWMF S1-Leitlinie Long-/Post-
COVID initiiert. In einem breiten interdisziplinären Ansatz wurde diese S1-Leitlinie …